Department of Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
Department of General, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany.
Int J Surg. 2016 Feb;26:64-8. doi: 10.1016/j.ijsu.2015.12.003. Epub 2015 Dec 29.
Previous reports showed an excellent survival for patients after resection of pancreatic metastases from renal cell cancer (pRCC) and reported several predictive factors. This study aims to give more evidence to reported risk factors by analyzing a large cohort of patients with pancreatic resection due to pRCC.
We retrospectively analyzed all pancreatic resections due to pRCC between January 1993 and October 2014 in two German pancreatic surgery centers. Predictive factors were analyzed using the chi square test.
Surgery was performed in 40 patients. Mean survival after resection was 147.9 months (SD 25.6 months). No predictive factors for survival were identified. Pathological examination showed that five out of 21 patients with examined peripancreatic lymph nodes had lymph node metastases.
Although our analysis comprised the biggest cohort of patients with pRCC it rendered no significant predictor for survival. This might be due to the overall excellent prognosis of study patients and the relatively rare condition with a limited number of patients. Several patients had lymph node metastases. Therefore lymphadenectomy should be considered in pRCC resection if the health condition of the patient permits this. By this more aggressive approach to pRCC, a better prognosis after resection might be achieved.
先前的报告显示,肾细胞癌(pRCC)转移至胰腺的患者在接受胰腺切除术后的生存情况极好,并报道了一些预测因素。本研究旨在通过分析大量因 pRCC 而行胰腺切除术的患者,为已报道的风险因素提供更多证据。
我们回顾性分析了 1993 年 1 月至 2014 年 10 月在两个德国胰腺外科中心接受胰腺切除术的所有因 pRCC 而接受手术的患者。使用卡方检验分析预测因素。
共对 40 例患者进行了手术。切除术后的平均生存时间为 147.9 个月(标准差为 25.6 个月)。未发现与生存相关的预测因素。对 21 例检查过的胰周淋巴结的患者进行了病理检查,其中 5 例有淋巴结转移。
尽管我们的分析包含了最大的因 pRCC 而行胰腺切除术的患者队列,但并未确定任何与生存相关的显著预测因素。这可能是由于研究患者的总体预后极好,以及该疾病相对罕见,患者数量有限。一些患者有淋巴结转移。因此,如果患者的健康状况允许,在进行 pRCC 切除时应考虑进行淋巴结清扫术。通过这种更积极的治疗方法,可能会获得更好的术后预后。